Glutaminase inhibitor compound (GIC) 968 that inhibits mitochondrial glutaminolysis, resulting in a rapid and specific elimination of senescent cells, and ferrostatin-1 that suppresses the cellular increase of oxidative stress, leading to survival of the cells, were used for the treatment of postmenopausal osteoporosis. Here, GLS is linked to postmenopausal osteoporosis.